• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$28.55 $0.10 (0.35%)

REAL-TIME: Last trade at

Medidata Solutions

NASDAQ:MDSO

INC Research Expands Partnership with Medidata Solutions

Stealth Stocks on the Move

Medidata Solutions, Inc. (MDSO) Reports In-Line Q1 EPS; Issues Mixed Q2, FY12 Revs Outlook

Medidata Solutions raises FY12 revenue view to $213M-$217M, consensus $211.54M

Medidata Solutions sees Q2 revenue $51.5M-$52.5M, consensus $52.82M

Medidata Solutions reports Q1 adj EPS 21c, consensus 22c

Medidata Solutions Reports First Quarter 2012 Results

TKL Research Selects Medidata Solutions’ Clinical Trial Management System to Drive Future Growth

2012 Economic Outlook -- Report Highlights Medidata Solutions, Inc. and AMETEK, Inc.

Medidata Solutions upgraded to Outperform from Market Perform at Raymond James

Medidata Solutions Schedules First Quarter Earnings Conference Call for May 1, 2012

Medidata Solutions Broadens the Capabilities of Its Cloud-based Randomization and Trial Supply Management Solution

Medidata Solutions Under Review

CTNeT Selects Medidata Solutions as Strategic IT Partner

Medidata Solutions Helps RTI International Address Evolving Research Technology Needs

Medidata Solutions jumps, resistance is at $27.31

Medidata Solutions upgraded to Buy from Hold at Jefferies

EXTEDO Joins Medidata Solutions Partner Program to Leverage Rave Safety Gateway

Medidata Solutions management to meet with Jefferies

Medidata Solutions management to meet with Needham

Japanese Contract Research Organization ACRONET Partners with Medidata Solutions

Medidata Solutions sees Q1 adjusted non-GAAP net income $4.5M-$5.5M

Medidata Solutions sees FY12 adjusted non-GAAP net income $25.5M-$28.5M

Medidata Solutions sees Q1 revenue $48.5M-$49.5M, consensus $47.89M

Medidata Solutions sees FY12 revenue to $210M-$215M, consensus $205.1M

Medidata Solutions reports Q4 EPS 37c, consensus 37c

Medidata Solutions, Inc. (MDSO) Reports In-Line Q4 EPS; Guides FY12, Q112 Sales

Medidata Solutions Reports Fourth Quarter and Full Year 2011 Results

Medidata Solutions recorded a Q4 non-cash GAAP tax benefit of 77c per share

Medidata Solutions sees FY12 effective tax rate 38%-42%

Medidata Solutions Provides Update on Tax Position and Litigation Settlement

8 Stocks Rising on Huge Volume

PROMETRIKA Selects Medidata Solutions as Strategic Partner

Vista Equity Partners reports 5.6% stake in Medidata Solutions

Medidata Solutions initiated with an Underweight at Piper Jaffray

Medidata Solutions Schedules Fourth Quarter Earnings Conference Call for March 6, 2012

Medidata Solutions downgraded to Hold from Buy at Jefferies

After-market Movers For Jan 25-NFLX, URI, LSI, SNDK, CVD, EFSC, NUVA, MDSO, MLNX

S&P Indices Announces Change to U.S. Index

Medidata Solutions to be added to S&P 600; RightNow deleted as of 1/27 close

See More Articles...